Stocks and Investing Stocks and Investing
Tue, June 18, 2024

Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $190 on, Jun 18th, 2024


Published on 2024-10-28 11:59:19 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $185 to $190 on, Jun 18th, 2024.

Christopher has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
  • Louise Chen of "Cantor Fitzgerald" Initiated at Buy and Held Target at $200 on, Friday, May 17th, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $187 on, Monday, April 29th, 2024
  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $180 on, Monday, April 29th, 2024
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
Contributing Sources